NYSE
10 hours, 24 minutes ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $575,000 through a pre-arranged Rule 10b5-1 trading plan.

NYSE
1 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 26, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
2 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $12.55 per share on June 25, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

NYSE
3 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock at an average price of $12.4876 per share, executed under a Rule 10b5-1 trading plan.

NYSE
4 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, through a pre-arranged 10b5-1 trading plan.

NYSE
7 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Reports Sale of 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 20, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
9 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 18, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
10 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 17, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
11 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 90,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 90,000 Class A Common Stock shares through a Rule 10b5-1 trading plan.

NYSE
15 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells $1.16 Million in Company Stock Under Pre-Arranged Plan
UiPath, Inc. CEO and Chairman Daniel Dines executed the sale of 90,000 shares of Class A Common Stock over two days in June 2025, totaling approximately $1.16 million, as part of a pre-established Rule 10b5-1 trading plan.

NYSE
17 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $593,491 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
18 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.08 per share, executed under a Rule 10b5-1 trading plan.

NYSE
21 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $589,779, executed under a Rule 10b5-1 trading plan.

NYSE
22 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines has sold 45,000 shares of Class A Common Stock for approximately $592,492 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
23 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 4, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
24 days, 11 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports Q1 2025 Revenue Growth Amidst Strategic Shift to AI and Cloud, Narrows Net Loss
UiPath, a leader in enterprise automation software, announced a 6% increase in total revenue to $356.6 million and a 12% rise in Annualized Renewal Run-Rate (ARR) to $1.69 billion for the first quarter ended April 30, 2025, while significantly narrowing its net loss.

NYSE
24 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 3, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
25 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.31 per share, executed under a Rule 10b5-1 trading plan.

NYSE
29 days, 11 hours ago 
PATH
Uipath, INC
8-K: UiPath Exceeds Q1 Fiscal 2026 Expectations with Strong ARR Growth and Agentic Automation Platform Launch
UiPath, a global leader in agentic automation, reported first quarter fiscal 2026 financial results that surpassed guidance, driven by robust ARR growth and the successful launch of its next-generation agentic automation platform.
Better than expected
 

NYSE
43 days, 10 hours ago 
PATH
Uipath, INC
SCHEDULE 13G: Bank of America Discloses 5.6% Stake in UiPath, Inc. Class A Common Stock
Bank of America Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of UiPath, Inc.'s Class A common stock as of March 31, 2025.

NYSE
44 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $13.176 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
45 days, 7 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath, Inc. Files Definitive Proxy Statement with SEC
UiPath, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.

NYSE
45 days, 11 hours ago 
PATH
Uipath, INC
DEF: UiPath Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
UiPath will hold its Annual Meeting of Stockholders virtually on June 26, 2025, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.
Worse than expected
 

NYSE
45 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $13.1224, according to a Form 4 filing.

NYSE
46 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.8332, pursuant to a pre-arranged 10b5-1 trading plan.

NYSE
49 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.5076, according to a Form 4 filing.

NYSE
50 days, 10 hours ago 
PATH
Uipath, INC
8-K: UiPath Director Laela Sturdy to Resign from Board at 2025 Annual Meeting
Laela Sturdy will resign from UiPath's Board of Directors prior to the 2025 Annual Meeting of Stockholders.

NYSE
50 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.1619, according to a Form 4 filing.

NYSE
51 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.0284, according to a Form 4 filing with the SEC.

NYSE
52 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 14,900 shares of Class A Common Stock at an average price of $12.0077 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
53 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 24,979 shares of Class A Common Stock at an average price of $12.0279 on May 5, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
56 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.0152, according to a Form 4 filing with the SEC.

NYSE
56 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Sells Shares Under 10b5-1 Plan
Ashim Gupta, COO & CFO of UiPath, sold 99,300 shares of Class A Common Stock on May 1, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
57 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO, Daniel Dines, executed a sale of 45,000 shares of Class A Common Stock at an average price of $12.0058, as part of a pre-arranged trading plan.

NYSE
81 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 12,500 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $10.1858, as part of a pre-arranged trading plan.

NYSE
85 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Stock Disposal for Tax Obligations
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports disposing of shares to cover tax obligations arising from vested restricted stock units.

NYSE
85 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Tax-Related Stock Disposal
Ashim Gupta, COO & CFO of UiPath, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.

NYSE
85 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Disposes of Shares to Cover Tax Obligations
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 22,595 shares of Class A Common Stock on April 1, 2025, to cover tax obligations arising from the vesting of restricted stock units.

NYSE
95 days, 10 hours ago 
PATH
Uipath, INC
10-K: UiPath's FY25 Revenue Climbs 9% Amid Strategic Shifts and AI Investments
UiPath reports a 9% increase in revenue for fiscal year 2025, driven by subscription growth and strategic investments in AI, while navigating leadership changes and macroeconomic headwinds.
Worse than expected
 

NYSE
101 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Award
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 93,065 shares of Class A Common Stock through Restricted Stock Units (RSUs).

PATH 
Uipath, INC 
NYSE

10-K: UiPath's FY25 Revenue Climbs 9% Amid Strategic Shifts and AI Investments

Sentiment:
 Annual Report on Form 10-K
 24 March 2025 5:27 PM

UiPath reports a 9% increase in revenue for fiscal year 2025, driven by subscription growth and strategic investments in AI, while navigating leadership changes and macroeconomic headwinds.

Worse than expected
  Revenue growth slowed to 9% compared to prior periods.  Gross margin decreased from 85% to 83%. 

Summary
  • UiPath's revenue for fiscal year 2025 reached $1,429.7 million, a 9% increase compared to the previous year.
  • Annual Recurring Revenue (ARR) grew by 14% to $1,666.1 million.
  • The company is focusing on agentic automation and expanding its platform with AI capabilities.
  • UiPath is managing costs through workforce restructuring and strategic resource allocation.
  • The company is navigating macroeconomic challenges, including geopolitical tensions and fluctuating inflation and interest rates.
  • UiPath is facing competition in the automation market, including from enterprise platform vendors and AI startups.
  • The company is subject to various regulations, including data privacy and security laws, and is investing in compliance efforts.
  • UiPath is involved in ongoing litigation, including securities class action suits and derivative actions.
Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While revenue and ARR are growing, the company is facing challenges such as increased competition, cost management, and ongoing litigation. The focus on AI and strategic shifts suggests a positive outlook, but the risks and uncertainties temper the overall sentiment.

Positives
  • Revenue and ARR are growing, indicating continued market demand for UiPath's platform.
  • The company is investing in AI and expanding its platform capabilities.
  • UiPath has a strong cash position, with $1,724.1 million in cash, cash equivalents, and marketable securities.
  • The company is actively managing its capital through a stock repurchase program.
  • UiPath has a large and diversified customer base across a broad range of industry sectors.
Negatives
  • The company has a history of net losses and may not achieve or sustain consistent profitability.
  • Gross margin decreased from 85% to 83% due to increased hosting and personnel costs.
  • The company is facing intense competition in the automation market.
  • UiPath is involved in ongoing litigation, including securities class action suits and derivative actions.
  • The company is subject to various regulations, including data privacy and security laws, and is investing in compliance efforts.
Risks
  • The company may not be able to successfully manage its growth.
  • Macroeconomic conditions and geopolitical tensions could adversely affect UiPath's business.
  • The company's past results may not be indicative of future performance.
  • Failure of the UiPath Platform to satisfy customer demands could adversely affect the business.
  • The company relies on existing customers renewing their licenses and purchasing additional licenses and products.
  • If UiPath is unable to attract new customers, its business will be adversely affected.
  • The markets in which UiPath participates are competitive.
  • If UiPath fails to retain and motivate members of its management team or other key employees, its business could be harmed.
  • A limited number of customers represent a substantial portion of UiPath's revenue and ARR.
  • UiPath relies on its channel partners to generate a substantial amount of its revenue.
  • If UiPath is not able to introduce and release new features or services successfully, its business could be adversely affected.
  • UiPath is subject to numerous risks associated with the evolving market for products with AI capabilities.
  • Risks associated with the use of AI in UiPath's platforms may result in reputational harm or liability.
  • Real or perceived errors, failures, or bugs in UiPath's platform and products could adversely affect its business.
  • Incorrect or improper implementation or use of UiPath's platform and products could result in customer dissatisfaction.
  • UiPath relies upon third-party providers of cloud-based infrastructure to host its cloud-based products.
  • If UiPath fails to maintain and enhance its brand, its ability to expand its customer base will be impaired.
  • UiPath and third parties with whom it does business are subject to stringent and evolving U.S. and foreign laws related to data privacy and security.
  • If UiPath's information technology systems or data are compromised, it could experience adverse consequences.
  • UiPath is subject to anti-corruption, anti-bribery, anti-money laundering, and similar laws.
  • Sales to government entities and highly regulated organizations are subject to a number of challenges and risks.
  • UiPath is subject to governmental export and import controls.
  • Any failure to obtain, maintain, protect, or enforce UiPath's intellectual property could impair its ability to protect its proprietary technology and its brand.
  • UiPath may become subject to intellectual property disputes.
  • UiPath's current operations are international in scope, creating a variety of operational challenges.
  • The dual class structure of UiPath's common stock has the effect of concentrating voting control with Daniel Dines, which will limit stockholders' ability to influence the outcome of important decisions.
Future Outlook

UiPath intends to deliver functionalities that increase the surface area of automation for its customers through the addition of agentic AI capabilities throughout the UiPath Platform and expects that its new agentic automation capabilities will enable it to expand sales within organizations as customers automate more complex workflows that require decision-making and benefit from a higher degree of agency.

Management Comments
  • AI-powered automation is here, and its momentum is continuing to grow as organizations around the world begin to understand the combined power of automation and AI to drive efficiency and accelerate business outcomes.
  • The UiPath Platform continues to shape the future of work as we evolve into an AI-native platform, where agentic AI is combined with RPA to not only help our customers automate workflows, but also to orchestrate and transform end-to-end business processes.
Industry Context

The automation market is fast-growing and increasingly competitive, with new technologies and market entrants. UiPath faces competition from enterprise platform vendors, RPA software providers, and AI startups.

Comparison to Industry Standards
  • The document does not provide enough information to compare UiPath's results to specific industry standards or comparable companies.
  • A detailed comparison would require benchmarking against competitors like Automation Anywhere, Blue Prism, Microsoft Power Automate, and other players in the RPA, AI, and BPM spaces.
  • Metrics such as revenue growth, ARR, customer acquisition cost, and retention rate would need to be compared to industry averages and specific competitor data to assess UiPath's relative performance.
Stakeholder Impact
  • Shareholders are impacted by the company's financial performance, strategic decisions, and litigation.
  • Employees are affected by workforce restructuring and changes in compensation and benefits.
  • Customers benefit from the company's investments in AI and platform enhancements.
  • Suppliers and partners are impacted by the company's financial stability and strategic relationships.
Next Steps
  • Continue to invest in research and development to enhance the UiPath Platform.
  • Expand the customer base and increase sales to existing customers.
  • Manage costs and improve profitability.
  • Navigate macroeconomic challenges and regulatory compliance.
  • Resolve ongoing litigation.
Legal Proceedings
  • UiPath and certain of its officers are parties to securities class action lawsuits and derivative actions alleging material misstatements and omissions.
  • The company is involved in ongoing tax audits in multiple jurisdictions.
Related Party Transactions
  • UiPath has at times made use of an aircraft which is owned by Daniel Dines, our co-founder and CEO, through a special purpose LLC and which is operated by a third-party aircraft management company.
Key Dates
  • 2005: UiPath was first established in Bucharest, Romania.
  • June 9, 2015: UiPath was incorporated in Delaware.
  • October 30, 2020: UiPath entered into a $200 million senior secured revolving Credit Facility.
  • April 2021: UiPath's IPO occurred.
  • July 2022: UiPath acquired Re:infer.
  • September 1, 2023: UiPath's board of directors authorized a stock repurchase program.
  • August 30, 2024: UiPath's board of directors authorized an additional $500 million for the stock repurchase program.
  • September 5, 2024: Ashim Gupta's offer letter date.
  • March 2025: UiPath acquired Peak AI Limited.
  • March 20, 2025: Date of share outstanding information.
Keywords
UiPath, revenue, ARR, automation, AI, financial results, stock repurchase, workforce restructuring, litigation, risk factors

PATH 
Uipath, INC 
NYSE
Sector: TBD
 
Filings with Classifications
Worse than expected
10 June 2025 5:28 PM

Insider Trading Report
  • The sale of shares by a high-ranking executive and significant shareholder, even under a Rule 10b5-1 plan, is generally viewed as a negative signal by the market, as it reduces the insider's direct stake in the company.
Worse than expected
5 June 2025 4:13 PM

SEC Form 4
  • The sale of shares by a key executive like the CEO, even if pre-planned, can be interpreted as a lack of confidence or a signal that the stock may not appreciate significantly in the near term, which is generally viewed as a negative indicator for investors.
Better than expected
29 May 2025 4:16 PM

Quarterly Report
  • First quarter results exceeded the company's guidance on both the top line (revenue) and bottom line (non-GAAP operating income).
  • Achieved significant year-over-year expansion in non-GAAP operating margin.
Worse than expected
13 May 2025 4:57 PM

Proxy Statement
  • The company's gross margin decreased from 85% in fiscal year 2024 to 83% in fiscal year 2025.
  • The company's cash and cash equivalents, restricted cash, and marketable securities decreased from $1,880.3 million as of January 31, 2024 to $1,724.1 million as of January 31, 2025.
Worse than expected
24 March 2025 5:27 PM

Annual Report on Form 10-K
  • Revenue growth slowed to 9% compared to prior periods.
  • Gross margin decreased from 85% to 83%.
Worse than expected
12 March 2025 4:23 PM

Earnings Release
  • The financial outlook for fiscal year 2026 reflects increasing global macro economic uncertainty, particularly in the U.S. public sector, resulting in lower revenue and ARR projections than previously anticipated.
Delay expected
12 March 2025 4:23 PM

Earnings Release
  • The restructuring costs are now expected to be incurred by the end of the second quarter of fiscal year 2026, extending the original timeline.
Worse than expected
6 December 2024 7:13 PM

Quarterly Report
  • The company's gross margin decreased to 82% for the quarter, down from 85% in the same quarter of the previous year.
  • The company reported a net loss of $10.7 million for the quarter and $125.5 million year-to-date.
  • Interest income decreased by 31% for the quarter due to lower cash balances and decreased interest rates.
Capital raise
6 December 2024 7:13 PM

Quarterly Report
  • The company may be required to seek additional equity or debt financing in the future.
Better than expected
5 December 2024 4:14 PM

Quarterly Report
  • The company's third quarter results exceeded expectations, reflecting improved execution and customer response to their new vision.
Worse than expected
6 September 2024 5:13 PM

Quarterly Report
  • The company's gross margin decreased from 83% to 80% due to increased costs in subscription services.
  • The operating loss increased from $77.6 million to $103.3 million year-over-year.
  • License revenue decreased by 6% year-over-year.
Better than expected
5 September 2024 4:17 PM

Quarterly Report
  • The company's ARR growth of 19% year-over-year exceeded expectations.
  • The company's non-GAAP adjusted free cash flow of $49 million was better than anticipated.
  • The company raised its full year profitability guidance.
Worse than expected
29 May 2024 4:25 PM

Executive Change Announcement
  • The unexpected resignation of the CEO is generally viewed negatively by the market.
Worse than expected
29 May 2024 4:18 PM

Quarterly Report
  • The company has lowered its full year revenue and operating margin guidance due to increased deal scrutiny and lengthening sales cycles.
Worse than expected
9 May 2024 5:00 PM

Proxy Statement
  • The company did not achieve 100% of its iARR target for fiscal year 2024, achieving 82% of the target.
Worse than expected
27 March 2024 5:26 PM

Annual Results
  • Despite revenue growth, the company reported a net loss for the year, indicating that profitability is still a challenge.
Better than expected
13 March 2024 4:17 PM

Quarterly Report
  • The company achieved its first quarter of GAAP profitability as a public company, which is better than expected.
  • The company's revenue and ARR growth exceeded expectations.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.